Skip to page content
Sorry, this comment period is now closed.
Draft Evidence Review
for the topic entitled
Breast Cancer: Medications for Risk Reduction, September 2019
is no longer accepting public comments
The public comment period expired on February 11, 2019 at 8:00 PM EST.